COVID-19 Related Content

A new biomarker for COVID-19? Researchers discover increased levels of the cytokine IL-26 in blood of acute patients.

Academic Research Scholar, Prof Wendy M. Purcell, provides an update on COVID-19, communicable disease and immunology.

Alison White, Founder & Director of White Workplace Consultancy Limited, examines how COVID-19 has changed the way we work & what we want from future workplaces.

The cost of living payments are designed to help households in the UK cope with increased food and fuel prices and rising energy bills.

The Covid-19 pandemic and emerging threats such as Monkeypox have demonstrated the need for global cooperation on public health.

COVID-19 activates the same inflammatory response in the brain as Parkinson’s disease – increasing the risk of future potential neurodegenerative conditions.

We enter Winter 2022 with our particular October volume of North America Analysis, crammed with insightful policy articles.

One only had to visit Heathrow in the summer of 2022 to see how the airline industry had been drastically affected by the effects of COVID-19.

We usher in Winter with our Asia Analysis October 2022 volume, which includes a choice selection of policy-oriented articles.

The long-standing hypothesis on personality traits may need re-evaluating after a study claims that the pandemic changed our personalities.

Digital transformation offers many organisations the opportunity to reduce costs, offer superior service and certainly, in Healthcare, improve outcomes. Paul Grosvenor, MD at Optima Systems, an information technology company based in West Sussex, recounts his experiences to date.

The Long COVID lessons learned beyond the COVID-19 pandemic are detailed here by leading Professors working on the University College London STIMULATE-ICP programme.

Following school closures due to COVID-19, schools need to reopen with safer designs in mind to protect students and help them attain an education.

Graham Watson, Executive Chair at InnoScot Health, explains how the firm’s special 20th anniversary celebrates international healthcare innovation success.

Transforming UK healthcare means tackling the NHS backlog from COVID-19, but this could be solved through digital improvements like AI and cloud data.

Plastic pollution has been an issue since the 1960s, but when mask-wearing, single-use plastics and hand sanitiser bottles became the norm, things only got worse.

CEO of ViewMind Inc, Mark Edwards, discusses the cognitive effects of Long COVID, aiming to understand the science behind brain fog and other COVID symptoms.

Dr Bahman Nedjat-Shokouhi, founder and CEO of Medefer, discusses how virtual outpatient care is the future of the NHS and how we need to prioritise funding for digital technologies that can pave the way for elective recovery.

The social development of young people was effected by the COVID-19 pandemic, the murder of George Floyd, and more global events.

Geospatial technology, or geographic information systems (GIS), has become an essential instrument in multiple areas today: agriculture and aviation, construction and commerce, climate research and law enforcement—the list could go on.